Myths vs Facts — Trans Feminine HRT
There is a lot of misinformation about hormone therapy — both from anti-trans sources and from well-meaning but misinformed individuals. This page addresses the most common myths with evidence-based facts.
Myth 1: "HRT is dangerous and causes major health problems"
Fact: Feminising HRT is considered safe when properly monitored, with risks comparable to or lower than many common medications.
The Endocrine Society, WPATH, the American Medical Association, and the American Psychological Association all recognise gender-affirming hormone therapy as medically necessary and evidence-based treatment for gender dysphoria.
The evidence
Multiple large-scale studies (including the 2019 Dutch cohort of 2,260 trans women and the ENIGI study across four European clinics) have found that feminising HRT carries a low rate of serious adverse events when appropriately monitored. The most significant risk — venous thromboembolism (VTE) — is primarily associated with oral estrogen in older individuals or those with pre-existing risk factors, and can be largely mitigated by using transdermal estradiol.
Myth 2: "You'll lose all your strength and become weak"
Fact: Muscle mass and strength decrease, but you will not become "weak."
Estrogen therapy reduces muscle mass, particularly in the upper body. Many trans women find they cannot lift as much as before. However, this is a gradual process and physical activity can maintain functional strength. Many trans women continue to participate in sports, weightlifting (at adjusted levels), and physically demanding work.
Myth 3: "HRT will make you sterile immediately"
Fact: Fertility decreases over time but is not guaranteed to be zero.
Sperm production reduces significantly as testosterone is suppressed. However:
- Some trans women retain fertility even after years on HRT
- Sterility is not reliably predictable for any individual
- HRT is not a contraceptive — pregnancy is possible even on HRT
If fertility preservation is important to you, consider sperm banking before starting HRT.
HRT is NOT birth control
Unprotected intercourse can still result in pregnancy even if you are on HRT and have low testosterone. Use reliable contraception if this is a concern.
Myth 4: "Your bones will become brittle without testosterone"
Fact: Estrogen is actually protective of bone health — it's low estrogen, not low testosterone, that causes bone density loss.
Bone health is maintained by having adequate levels of either estrogen or testosterone. Since feminising HRT provides estrogen, bone density is generally well-preserved or improved. The concern is only relevant if both hormones are suppressed — which should not happen with proper HRT.
Target range matters
Keeping estradiol levels in the 100–200 pg/mL range is important for bone health. Low E2 levels on both the pre-HRT and post-HRT sides of transition are what cause bone density problems. Adequate calcium and vitamin D intake also supports bone health during HRT.
Myth 5: "Progesterone is essential for breast growth"
Fact: Progesterone may help with breast maturation, but it is not necessary for breast development.
Many trans women achieve satisfactory breast development on estrogen alone. Progesterone is sometimes added after 6–12 months for possible benefits in breast shape (Tanner stage 4/5), libido, and mood — but the evidence is largely anecdotal, and clinical studies remain limited. Some women experience negative side effects from progesterone.
Myth 6: "Trans women grow 'man boobs' not real breasts"
Fact: Trans women on HRT develop breasts composed of the same glandular tissue as cisgender women.
Breast tissue is breast tissue. Under the influence of estrogen, trans women develop mammary glands, ducts, fat, and connective tissue — the same components as cisgender women. The breasts may differ in shape or size on average (often wider-set with a broader chest wall), but they are structurally the same.
Myth 7: "HRT will completely remove your body hair"
Fact: HRT slows body hair growth and makes hairs finer and lighter, but it does not remove existing terminal hair.
Terminal hair (thick, dark hair on face, chest, back, etc.) that developed during testosterone-driven puberty will not disappear with estrogen alone. It will grow more slowly and may become less coarse, but permanent removal requires laser hair removal or electrolysis.
Myth 8: "HRT will change your voice"
Fact: Estrogen does not affect the vocal cords or larynx.
Voice deepening during male puberty is caused by testosterone thickening the vocal cords and enlarging the larynx. Estrogen cannot reverse this. Trans women who want a more feminine-sounding voice typically pursue voice training (voice therapy) or, less commonly, vocal feminisation surgery.
Myth 9: "Starting HRT after 30 won't work"
Fact: Trans women start HRT successfully at all ages — 18, 30, 50, 70+.
While younger individuals may experience faster or more pronounced physical changes (particularly in fat redistribution), people who start HRT later in life still get meaningful feminisation. Breast development, skin softening, emotional changes, fat redistribution, and the psychological benefits of HRT all occur across age groups.
Myth 10: "You have to be on HRT for life — once you start you can't stop"
Fact: HRT is a long-term medication, but you can stop at any time.
If you stop taking estrogen and anti-androgens, your testosterone will typically return to pre-HRT levels over weeks to months. Some changes will reverse (muscle mass, fat distribution, skin changes) and some are permanent (breast tissue, fertility changes). Many trans women choose to stay on HRT indefinitely for both its physical and psychological benefits.
Myth 11: "Birth control pills are the same as HRT estrogen"
Fact: Birth control pills contain synthetic estrogen (ethinylestradiol), which is not recommended for feminising HRT.
Ethinylestradiol carries a significantly higher risk of blood clots (VTE) compared to bioidentical 17β-estradiol (estradiol valerate, estradiol hemihydrate, etc.). DIY HRT guides always recommend bioidentical estradiol, never birth control pills.
Myth 12: "DIY HRT is impossible to do safely"
Fact: While prescribed HRT with medical supervision is ideal, DIY HRT can be done relatively safely with proper education, blood testing, and quality-controlled sources.
The key requirements:
- Blood tests every 3 months (at least in the first year)
- Reputable sources with verified product quality
- Thorough self-education on dosing, side effects, and emergency signs
- Regular monitoring of hormone levels, blood pressure, and overall health
Many trans people use DIY HRT because they face waiting lists of years, gatekeeping, or high costs in their country. It is a pragmatic choice when prescribed care is not accessible.
Myth 13: "Cyproterone acetate (CPA) is safe at any dose"
Fact: CPA carries a dose-dependent risk of meningioma (a usually benign brain tumour).
The risk increases with cumulative dose and duration. Historically, CPA was prescribed at 50–100 mg/day for trans women — far higher than necessary. Current best practice recommends 10–12.5 mg/day as sufficient for testosterone suppression in most people. Note that the European Medicines Agency (EMA) formally restricts all medicines with CPA doses ≥10 mg/day (2020 PRAC ruling), so 12.5 mg/day is within the restricted range — this is a harm reduction choice, not a ceiling below regulatory concern. CPA is contraindicated in anyone with a history of meningioma.
Myth 14: "Anti-androgens are always necessary"
Fact: Some trans women achieve adequate testosterone suppression on estrogen alone (monotherapy).
High-dose injectable or transdermal estradiol can suppress testosterone via negative feedback on the HPG axis in some individuals. However, oral estrogen monotherapy is not recommended due to increased VTE risk at high doses. Monotherapy success varies; some people will always need an anti-androgen to reach target T levels.
Myth 15: "You need a therapist's letter to start HRT"
Fact: This depends on where you live and whether you pursue prescribed or DIY care.
For prescribed HRT, many countries still require a therapist's referral or a diagnosis of gender dysphoria (though this is changing — informed consent models are becoming more common). For DIY HRT, no prescription is needed, but you take full responsibility for your own care.
References
Hembree WC, et al. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons. JCEM. https://academic.oup.com/jcem/article/102/11/3869/4157558
WPATH (2022). Standards of Care, Version 8. https://www.tandfonline.com/doi/full/10.1080/26895269.2022.2100644
de Blok CJM, et al. (2019). Breast cancer risk in transgender people receiving hormone treatment. BMJ. https://www.bmj.com/content/365/bmj.l1652
Nota NM, et al. (2019). Occurrence of acute cardiovascular events in transgender individuals receiving hormone therapy. Circulation. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.038584